Verdence Capital Advisors LLC Has $529,000 Stock Holdings in Encompass Health Corporation $EHC

Verdence Capital Advisors LLC cut its stake in Encompass Health Corporation (NYSE:EHC) by 18.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,312 shares of the company’s stock after selling 985 shares during the quarter. Verdence Capital Advisors LLC’s holdings in Encompass Health were worth $529,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of EHC. Congress Asset Management Co. acquired a new position in shares of Encompass Health in the second quarter worth $92,691,000. Nuveen LLC acquired a new position in shares of Encompass Health in the first quarter worth $50,665,000. T. Rowe Price Investment Management Inc. increased its stake in shares of Encompass Health by 25.6% in the first quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company’s stock worth $210,756,000 after acquiring an additional 424,691 shares during the last quarter. Strs Ohio acquired a new position in shares of Encompass Health in the first quarter worth $34,364,000. Finally, American Century Companies Inc. increased its stake in shares of Encompass Health by 78.6% in the first quarter. American Century Companies Inc. now owns 723,169 shares of the company’s stock worth $73,243,000 after acquiring an additional 318,251 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. KeyCorp increased their target price on shares of Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 16th. UBS Group increased their target price on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Thursday, October 2nd. Bank of America increased their target price on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Finally, Truist Financial increased their target price on shares of Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a research report on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating and eight have issued a Buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $139.86.

Encompass Health Stock Up 1.4%

NYSE EHC opened at $122.95 on Wednesday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The firm has a 50-day simple moving average of $123.14 and a 200 day simple moving average of $116.80. Encompass Health Corporation has a twelve month low of $87.85 and a twelve month high of $127.86. The stock has a market cap of $12.38 billion, a PE ratio of 24.06, a PEG ratio of 2.12 and a beta of 0.93.

Encompass Health (NYSE:EHC) last released its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The business had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, research analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a dividend of $0.19 per share. This is a positive change from Encompass Health’s previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Wednesday, October 1st. Encompass Health’s dividend payout ratio is 14.87%.

Insider Buying and Selling

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the firm’s stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the transaction, the executive vice president owned 18,846 shares in the company, valued at $2,329,177.14. This trade represents a 5.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.10% of the stock is currently owned by corporate insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.